01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2017–FY2022. Drag across the bars to change the range.
- $1.04B
2 older moves run past ±150% (largest +341.5%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2022 | $1.04B | +341.5% | 10-K | |
| FY2021 | $236.0M | −63.0% | 10-K | |
| FY2020 | $638.0M | +186.1% | 10-K | |
| FY2019 | $223.0M | −87.6% | 10-K | |
| FY2018 | $1.79B | +32.9% | 10-K | |
| FY2017 | $1.35B | −54.8% | 10-K | |
| FY2016 | $2.99B | −37.3% | 10-K | |
| FY2015 | $4.77B | +13.6% | 10-K | |
| FY2014 | $4.20B | +90.3% | 10-K | |
| FY2013 | $2.21B | −36.4% | 10-K | |
| FY2012 | $3.47B | +12.6% | 10-K | |
| FY2011 | $3.08B | −10.1% | 10-K | |
| FY2010 | $3.43B | +29.1% | 10-K | |
| FY2009 | $2.65B | +4.1% | 10-K | |
| FY2008 | $2.55B | +100.6% | 10-K | |
| FY2007 | $1.27B | — | 10-K |
03—Questions
What is Teva Pharmaceutical Industries's current free cash flow?
Teva Pharmaceutical Industries (TEVA) annual free cash flow for 2022 was $1.04B, a 341.53% increase from 2021. Teva Pharmaceutical Industries free cash flow for the quarter ending June 30, 2023 was $205.0M.
What was Teva Pharmaceutical Industries's free cash flow in 2021?
Teva Pharmaceutical Industries annual free cash flow for 2021 was $236.0M, a 63.01% decline from 2020.
What was Teva Pharmaceutical Industries's free cash flow in 2020?
Teva Pharmaceutical Industries annual free cash flow for 2020 was $638.0M, a 186.10% increase from 2019.
What is Teva Pharmaceutical Industries's 5-year free cash flow CAGR?
Teva Pharmaceutical Industries free cash flow grew at a compound annual growth rate (CAGR) of 5.06% from FY2017 to FY2022, going from $1.35B to $1.04B over 5 years.
- Company
- Teva Pharmaceutical Industries
- Ticker
- TEVA
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations